[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health":3,"$f2akyx7epx23af":14},{"ok":4,"db":5,"lastOrangeBookRun":6,"lastDrugsFdaRun":9,"lastAlertsRun":12,"stale":13},true,"ok",{"status":5,"startedAt":7,"finishedAt":8,"lastOkAt":8},"2026-10-26T06:44:32.239Z","2026-10-26T06:44:53.640Z",{"status":5,"startedAt":10,"finishedAt":11,"lastOkAt":11},"2026-10-26T06:45:02.648Z","2026-10-26T06:45:13.189Z",null,false,{"tradeName":15,"ingredient":16,"applicant":17,"applicantSlug":18,"applNos":19,"loe":21,"latestLoe":21,"basis":22,"carveOutPossible":13,"openStrengths":23,"headlineStrengths":24,"headlineFallback":13,"approvalsBeforeLoe":23,"products":25,"patents":40,"exclusivities":49,"paragraphIv":50,"catalysts":52},"ACTOPLUS MET","METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE","TAKEDA PHARMS USA","takeda-pharms-usa",[20],"021842","2029-02-03","patent",0,1,[26,34],{"key":27,"applNo":20,"productNo":28,"dosageForm":29,"route":30,"strength":31,"approvalDate":32,"rld":4,"teCode":12,"type":33,"loe":21,"basis":22,"carveOutPossible":13},"021842-001","001","TABLET","ORAL","500MG;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**","2005-08-29","DISCN",{"key":35,"applNo":20,"productNo":36,"dosageForm":29,"route":30,"strength":37,"approvalDate":32,"rld":4,"teCode":38,"type":39,"loe":21,"basis":22,"carveOutPossible":13},"021842-002","002","850MG;EQ 15MG BASE","AB","RX",[41,45],{"product":27,"patentNo":42,"expireDate":21,"drugSubstance":13,"drugProduct":4,"useCode":12,"delisted":13,"pediatricExt":13,"submissionDate":43,"products":44},"9320714","2016-05-20",2,{"product":35,"patentNo":46,"expireDate":47,"drugSubstance":13,"drugProduct":4,"useCode":12,"delisted":13,"pediatricExt":13,"submissionDate":48,"products":44},"9101660","2027-01-22","2015-09-10",[],{"asOf":12,"firstFiled":12,"entries":51},[],[]]